• Profile
Close

Association of body mass index, central obesity, and body composition with mortality among Black breast cancer survivors

JAMA Aug 25, 2021

Bandera EV, Qin B, Lin Y, et al. - Central obesity and higher adiposity were correlated with higher all-cause and breast cancer-specific mortality among Black breast cancer survivors in this population-based cohort study. It has been reported that simple measures of body fat distribution and body composition were useful tools for distinguishing Black women with a higher risk of death after a breast cancer diagnosis.

  • The mean (SD) age at breast cancer diagnosis was 54.5 (10.8) years among 1,891 women. In this study, 286 deaths were identified during a median follow-up of 5.9 years (range, 0.5-14.8 years); of those, 175 deaths (61.2%) were associated with breast cancer.

  • Results showed that a sum of 1,060 women (56.1%) had obesity, and 1,291 women (68.3%) had central obesity.

  • Higher adiposity, especially a higher waist-to-hip ratio, was correlated with worse survival.

  • In comparison with women in the lowest quartile, women in the highest quartile of waist-to-hip ratio had a 61% increased risk of dying from any cause (hazard ratio [HR], 1.61; 95% CI, 1.12-2.33) and a 68% increased risk of breast cancer death (HR, 1.68; 95% CI, 1.04-2.71).

  • It was shown that the risks of all-cause and breast cancer-specific death were similarly high among women in the highest quartile for waist circumference (HR, 1.74 [95% CI, 1.26-2.41] and 1.64 [95% CI, 1.08-2.48], respectively), percent body fat (HR, 1.53 [95% CI, 1.09-2.15] and 1.81 [95% CI, 1.17-2.80]), and fat mass index (HR, 1.57 [95% CI, 1.11-2.22] and 1.74 [95% CI, 1.10-2.75]); nevertheless, the risk was less substantial for body mass index (HR, 1.26 [95% CI, 0.89-1.79] and 1.33 [95% CI, 0.84-2.10]).

  • A higher waist-to-hip ratio was correlated with a higher risk of all-cause death among women who had estrogen receptor-negative tumors (HR, 2.24; 95% CI, 1.14-4.41), women who were postmenopausal (HR, 2.15; 95% CI, 1.28-3.61), and women who were 60 years or older at diagnosis (HR per 0.10-U increase, 1.76; 95% CI, 1.37-2.26) in analyses stratified by estrogen receptor status, menopausal status, and age.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay